The Rome V criteria for IBS identified a different group of patients, with lower sensitivity than either Rome III or IV ...
Inviting patients to undergo combined Helicobacter pylori stool antigen testing with fecal immunochemical testing (FIT) yielded superior cost-effectiveness compared with FIT alone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results